<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Klein, Pavel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Brivaracetam Reduces Seizure Frequency in Patients With Partial-Onset Seizures</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-05-20 11:31:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-13</style></pages><abstract><style  face="normal" font="default" size="100%">Results of a phase 3 study indicate that adjunctive treatment with brivaracetam can significantly reduce the frequency of partial-onset seizures previously refractory to pharmacotherapy and improve responder rates. Patients receiving brivaracetam also had a higher rate of seizure freedom during treatment compared with those receiving placebo. Brivaracetam is safe and well tolerated.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>